Europe: European healthcare companies raise early-stage funding

Over the past week, European healthcare companies have been at the forefront of raising early-stage capital. In the Netherlands, Salvia BioElectronics has raised €26m (US$31m) to develop innovative neurostimulation therapy for chronic migraine The Series A investment round was led by Panakès Partners, INKEF Capital and SHS Gesellschaft für Beteiligungsmanagement with participation from BOM Brabant…

You must be a HMI Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »